This article is more than 5 years old. Information may no longer be current.

Nike MaxSight daily wear lens granted FDA approval

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — A “sport-tinted” contact lens designed to aid visual performance in athletic settings has received U.S. marketing clearance, according to the marketer.

Bausch & Lomb’s Nike MaxSight (polymacon) Sport-Tinted Contact Lens is indicated for daily wear for the correction of refractive myopia and hyperopia, according to a B&L press release. The Nike MaxSight “selectively filters specific wavelengths of light within the visible spectrum to enhance key visual elements such as a ball or background while reducing distracting sun glare during various outdoor sporting activities,” the B&L release stated.

Nike and B&L partnered 3 years ago to develop the lens. Nike will market the lens to consumers while B&L will manufacture and market the lens to eye care professionals.

The Nike MaxSight will launch in both the United States and Europe in late summer in two tints: gray-green, designed for sports played in bright sunlight, and amber, designed for “fast-moving ball sports,” such as soccer, tennis, baseball and softball, played in variable light.